Poly Medicure (NSE:POLYMED) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)


NSE:POLYMED Poly Medicure Ltd NSE:POLYMED
92 GF Score
Price ₹1,677.80
GF Value ₹2,308.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Poly Medicure Cash Flow for Dividends?

Poly Medicure NSE:POLYMED -3.15% 92 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:POLYMED with a GF Score™ of 92/100 and a GF Value™ of ₹2,308.36 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Poly Medicure's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Poly Medicure's annual payment of dividends increased from Mar. 2024 (₹-287 Mil) to Mar. 2025 (₹-303 Mil) and increased from Mar. 2025 (₹-303 Mil) to Mar. 2026 (₹-354 Mil).

Poly Medicure Cash Flow for Dividends Related Terms

Poly Medicure Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Poly Medicure's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poly Medicure Cash Flow for Dividends Chart

Poly Medicure Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -239.16 -239.73 -287.40 -303.41 -354.31

Poly Medicure Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:POLYMED
92GF Score
Poly Medicure Ltd NSE:POLYMED
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poly Medicure Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Poly Medicure (NSE:POLYMED) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Poly Medicure and its competitors.
Is Poly Medicure's Cash Flow for Dividends too high?
Poly Medicure's current Cash Flow for Dividends is ₹0 Mil. Overall, Poly Medicure has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Cash Flow for Dividends compare to ISRG and BDX?
Poly Medicure's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Poly Medicure and its competitors. Poly Medicure's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,308.36, compared to a current price of ₹1,677.80 — trading 27.3% below its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. Poly Medicure's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?

Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued. The current stock price of ₹1,677.80 is trading 27.3% below its estimated GF Value™ of ₹2,308.36. GuruFocus considers Poly Medicure to be Modestly Undervalued.

Key valuation signals for NSE:POLYMED:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹2,308.36 vs. price of ₹1,677.80 (27.3% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poly Medicure Business Description

Other Exchanges 531768:India
Address Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
92GF Score

Get the complete analysis for NSE:POLYMED

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,677.80
Price
₹2,308.36
GF Value